Moneycontrol PRO
HomeNewsBusinessMarketsClosing Bell: Nifty closes just below 10,900, Sensex up 300 points led by metal, energy stocks
Live now
auto refresh

Closing Bell: Nifty closes just below 10,900, Sensex up 300 points led by metal, energy stocks

All sectoral indices are trading in the green, with metals, energy and pharmaceutical indices leading the top gainers’ chart.

December 17, 2018 / 15:35 IST
  • Moneycontrol.com
  • IndexPricesChangeChange%
    Sensex84,562.7884.11 +0.10%
    Nifty 5025,910.0530.90 +0.12%
    Nifty Bank58,517.55135.60 +0.23%
    Nifty 50 25,910.05 30.90 (0.12%)
    Fri, Nov 14, 2025
    Biggest GainerPricesChangeChange%
    Eternal303.756.00 +2.02%
    Biggest LoserPricesChangeChange%
    Infosys1,502.80-39.00 -2.53%
    Best SectorPricesChangeChange%
    Nifty PSU Bank8399.9096.85 +1.17%
    Worst SectorPricesChangeChange%
    Nifty IT36301.30-378.10 -1.03%


  • December 17, 2018 / 15:35 IST

    Market at close:

    Benchmark indices ended on strong note with Sensex closed up 300 points, while Nifty ended just below 10,900.

    At the close, the Sensex was up 307.14 points at 36,270.07, while Nifty was up 82.90 points at 10,888.40. About 1400 shares have advanced, 1192 shares declined, and 150 shares are unchanged.

    Power Grid Corp, Tata Motors, HDFC, Coal India and Vedanta are the top gainers on the Sensex, while Kotak Mahindra Bank, Infosys, Bharti Airtel, Hero Motocorp and L&T are among major losers.

    All the sectoral indices ended in green led by metal (up 2 percent) and energy stocks (up 1.5 percent) followed by auto, bank, infra and pharma space.

  • December 17, 2018 / 15:25 IST

    Coal India to consider interim  dividend:

    A meeting of the Board of Directors of the company is scheduled on December 20 to consider and approve payment of Interim Dividend, if any, for the year 2018-19.

  • December 17, 2018 / 14:45 IST

    Just IN

    |Lupin has received approval for its Clobazam Tablets, 10 mg and 20 mg from the United States Food and Drug Administration (FDA).

  • December 17, 2018 / 14:37 IST

    BGR Energy Systems bags order:

    Company has secured an order from Tamilnadu Transmission Corporation of Rs 49.40 crore inclusive of GST and the contract completion period is 10 months.

  • December 17, 2018 / 14:00 IST

    Lupin gets USFDA approval:

    Company has received tentative approval for its Tadalafil Tablets USP, 20 mg from the United States Food and Drug Administration (FDA) to market a generic version of Eli Lilly and Company's (Lilly) Adcirca Tablets, 20 mg.

  • December 17, 2018 / 13:37 IST

    Rupee Update

    The Indian rupee is trading higher by 25paise71.65 per dollar versus Friday's close 71.90.

  • December 17, 2018 / 12:31 IST

    ROADBLOCK |

    Malaysia's IHH Healthcare Monday said it will not be able to proceed with the open offer for Fortis Healthcare for the time being, following the Supreme Court order to put on hold sale of controlling stake in the Indian hospital chain.

  • December 17, 2018 / 12:19 IST

    Reuters reported that oil prices were largely steady on Monday after falling 2 percent in the previous session, but remained under pressure amid weaker growth in major economies and concerns about oversupply.

    International Brent crude oil futures were at $60.33 per barrel at 0423 GMT, up 5 cents, or 0.08 percent, from their last close.

    U.S. West Texas Intermediate (WTI) crude futures were at $51.33 per barrel, up 13 cents, or 0.25 percent.

    Persistent growth in U.S. shale output continues to weigh on oil prices, while some analysts doubted that planned supply cuts led by the Organization of the Petroleum Exporting Countries would be enough to rebalance markets.

  • December 17, 2018 / 11:58 IST

    ALERT |

    Ahluwalia Contracts has bagged an order worth Rs 425.4 crore in Bihar.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347